home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Medical Device cybersecurity following latest FDA Guidance

  November 16, 2018  
Compliancetrainingpanel, Usa

Description :
The company must establish a program where they identify, analyze and control cybersecurity risks for both pre market and post market. The cybersecurity program must be carefully planned. A formal special hazard analysis must be conducted for each risk. Communication of risks must be sent to device users. A complex set of reporting requirements has been established. This webinar will describe a program that will be compliant to the FDA requirements.

Why :
Medical device cybersecurity has become very important to the FDA. They have recently issued two Guidance’s on the subject; the latest in December of 2016. FDA expects a proactive extensive risk based program to minimize risk to the user from cyber attacks including active involvement with information sharing groups.

Areas Covered in the Session :

1.     Cybersecurity plan

2.     Risk based analysis

3.     Hazard analysis following ISO14971

4.     Risk communication to users

5.     Required membership in information sharing groups

6.     Reporting requirements and the exceptions

Who Will Benefit:

1.     company management

2.     IT personnel

3.     Development Engineers

4.     Production Management

5.     QA/ QC personnel

6.     Software developers

Venue: Online
Speaker Name:Edwin Wald busser
Priice : $ 229
Wednesday Nov28 , 2018
EST 13:00
Duration : 60 Minutes

Organized by: Compliancetrainingpanel
Invited Speakers:

Edwin Waldbusser

Edwin Waldbusser retired from industry after 20 years in management of development of medical device products and development of company Quality Systems. Products included IVD devices, kidney dialysis systems and inhalation devices. QS experience includes design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing/ non-conforming product programs.


Deadline for Abstracts: 28-11-2018
Registration: Compliancetrainingpanel
E-mail: event@compliancetrainingpanel.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.